Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26 GBX | 0.00% | 0.00% | -43.48% |
Apr. 05 | Transcript : LungLife AI, Inc., 2023 Earnings Call, Apr 05, 2024 | |
Apr. 04 | LungLife reports narrowed losses in year of "considerable achievement" | AN |
Financials (USD)
Sales 2024 * | 100K | Sales 2025 * | 500K | Capitalization | 9.98M |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | - | EV / Sales 2024 * | 93.8 x |
Net cash position 2024 * | 600K | Net cash position 2025 * | 500K | EV / Sales 2025 * | 19 x |
P/E ratio 2024 * |
-2.45
x | P/E ratio 2025 * |
82
x | Employees | 15 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.29% |
Latest transcript on LungLife AI, Inc.
Current month | -8.77% | ||
1 month | -22.39% | ||
3 months | -42.86% | ||
6 months | -69.41% | ||
Current year | -43.48% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Pagano
CEO | Chief Executive Officer | 40 | - |
David Anderson
DFI | Director of Finance/CFO | 61 | - |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gordon Davis
CHM | Chairman | 67 | 21-07-07 |
Andrew Boteler
BRD | Director/Board Member | 58 | 21-07-07 |
David Anderson
DFI | Director of Finance/CFO | 61 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 26 | 0.00% | 18,615 |
24-05-09 | 26 | 0.00% | 2,250 |
24-05-08 | 26 | 0.00% | 12,811 |
24-05-07 | 26 | 0.00% | 0 |
24-05-03 | 26 | -1.89% | 122,013 |
Delayed Quote London S.E., May 10, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.48% | 9.98M | |
-27.67% | 9.87B | |
-17.30% | 2.74B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+59.69% | 1.39B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M |
- Stock Market
- Equities
- LLAI Stock